35 per cent returns from 52-week low; Company Expands Globally with GBP 239 Million Acquisition of Comfort Click Limited

Zydus Wellness Limited (ZWL), a leading Indian consumer health and wellness company, has announced its entry into international markets with the acquisition of Comfort Click Limited (CCL), a UK-based digital consumer healthcare platform. The deal, valued at GBP 239 million plus an agreed profit ticker, represents Zydus Wellness’s first overseas acquisition and a strategic move into the growing Vitamins, Minerals, and Supplements (VMS) segment.

The acquisition was executed through Alidac UK Limited, a wholly-owned subsidiary of ZWL. Alidac acquired 100 per cent of the outstanding ordinary shares of Class A and Class B, along with 71.43 per cent of Class C and 66.67 per cent of Class D shares. With this, CCL has become a wholly-owned subsidiary of Alidac and a step-down subsidiary of ZWL. The transaction, completed on August 29, 2025, was executed for cash consideration.

About Comfort Click Limited

Founded in 2005, Comfort Click operates in the VMS segment and is recognised among Europe’s fastest-growing digital healthcare platforms, featured in the Financial Times’ top 1000 fastest-growing companies list in 2024 and 2025. With a strong presence across the UK and Europe, and ongoing expansion in the USA, CCL also runs subsidiaries in India, Ireland, and the USA.

Its portfolio spans across adult, kids, and pet segments through three brands:

• WeightWorld™: Plant-based supplements, vitamins, minerals, probiotics, collagen, omegas, and sports nutrition for adults.
• maxmedix™: Speciality VMS gummies for paediatric nutrition.
• Animigo: Natural VMS products for pets.

Most of Comfort Click’s revenue is generated via e-commerce and Direct-to-Consumer (D2C) channels. For FY ending June 30, 2025, CCL reported revenue of GBP 134 million with an adjusted EBITDA of GBP 21 million. Previous revenues stood at GBP 85 million in FY 2024 and GBP 52 million in FY 2023, reflecting a five-year CAGR of 57 per cent.

Strategic Rationale

The acquisition enhances Zydus Wellness’s global presence in consumer health, digital health, and personalised wellness. Commenting on the move, Dr. Sharvil Patel, Chairman, Zydus Wellness, said that the acquisition strengthens the company’s digital-first capabilities and consumer-centric approach in the wellness sector. CEO Tarun Arora added that the acquisition brings scale, innovation, and growth potential to ZWL’s portfolio.

The deal is not classified as a related party transaction, and no promoter group companies of ZWL have any interest in CCL. Regulatory approvals were not required, and the existing CCL management will continue operations while reinvesting part of their proceeds into Growth Shares. The transaction is also expected to be Cash EPS accretive.

Market Context

The European VMS market is valued at around GBP 11 billion, while the global digital VMS market is projected to grow at 7–9 per cent CAGR to reach USD 50–60 billion by 2030. Increasing health awareness, preventive healthcare adoption, and the rise of digital platforms are driving growth.

About Zydus Wellness

Zydus Wellness operates in Food & Nutrition with brands like Sugar Free, Complan, Glucon-D, Nutralite, Ritebite Max Protein, and I’Mlite, and in Personal Care with Everyuth and Nycil. With this acquisition, ZWL has taken a key step in its strategy of expanding international presence and strengthening capabilities in consumer wellness.

The company has a market capitalisation of over Rs 12,800 crore and the stock is up by 35 per cent from its 52-week low of Rs 1,493 per share.

Disclaimer: The article is for informational purposes only and not investment advice.